- Home
- BCRX vs GDRX Comparison
BCRX vs GDRX Comparison
Compare BCRX & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- GDRX
- Stock Information
- Founded
- BCRX 1986
- GDRX 2011
- Country
- BCRX United States
- GDRX United States
- Employees
- BCRX N/A
- GDRX N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- GDRX Retail: Computer Software & Peripheral Equipment
- Sector
- BCRX Health Care
- GDRX Technology
- Exchange
- BCRX Nasdaq
- GDRX Nasdaq
- Market Cap
- BCRX 1.7B
- GDRX N/A
- IPO Year
- BCRX 1994
- GDRX 2020
- Fundamental
- Price
- BCRX $9.92
- GDRX $4.24
- Analyst Decision
- BCRX Buy
- GDRX Buy
- Analyst Count
- BCRX 8
- GDRX 11
- Target Price
- BCRX $16.75
- GDRX $8.30
- AVG Volume (30 Days)
- BCRX 5.7M
- GDRX 1.5M
- Earning Date
- BCRX 05-05-2025
- GDRX 05-07-2025
- Dividend Yield
- BCRX N/A
- GDRX N/A
- EPS Growth
- BCRX N/A
- GDRX N/A
- EPS
- BCRX N/A
- GDRX 0.07
- Revenue
- BCRX $503,485,000.00
- GDRX $797,414,000.00
- Revenue This Year
- BCRX $27.64
- GDRX $5.98
- Revenue Next Year
- BCRX $13.42
- GDRX $6.38
- P/E Ratio
- BCRX N/A
- GDRX $58.81
- Revenue Growth
- BCRX 41.67
- GDRX 4.35
- 52 Week Low
- BCRX $5.06
- GDRX $3.82
- 52 Week High
- BCRX $11.11
- GDRX $9.26
- Technical
- Relative Strength Index (RSI)
- BCRX 65.51
- GDRX 44.46
- Support Level
- BCRX $8.28
- GDRX $3.68
- Resistance Level
- BCRX $11.11
- GDRX $4.80
- Average True Range (ATR)
- BCRX 0.51
- GDRX 0.25
- MACD
- BCRX 0.25
- GDRX -0.05
- Stochastic Oscillator
- BCRX 69.17
- GDRX 48.50
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.